Biomarin Pharmaceuticals (NQ: BMRN )

80.97 -1.25 (-1.51%)
Streaming Delayed Price Updated: 1:00 PM EDT, Jul 3, 2024 Add to My Watchlist

Insider Filings

Form 4
Source: SEC/Edgar
March 23, 2017
Form 4
Source: SEC/Edgar
March 23, 2017
Form 4
Source: SEC/Edgar
March 23, 2017
Form 4
Source: SEC/Edgar
March 23, 2017
Form 4
Source: SEC/Edgar
March 23, 2017
Form 4
Source: SEC/Edgar
March 23, 2017
Form 4
Source: SEC/Edgar
March 16, 2017
Form 4
Source: SEC/Edgar
March 16, 2017
Form 4
Source: SEC/Edgar
March 16, 2017
Form 4
Source: SEC/Edgar
March 16, 2017
Form 4
Source: SEC/Edgar
March 16, 2017
Form 4
Source: SEC/Edgar
March 16, 2017
Form 4
Source: SEC/Edgar
March 16, 2017
Form 4
Source: SEC/Edgar
March 14, 2017
Form 4
Source: SEC/Edgar
March 12, 2017
Form 4
Source: SEC/Edgar
March 07, 2017
Form 4
Source: SEC/Edgar
March 07, 2017
Form 4
Source: SEC/Edgar
March 07, 2017
Form 4
Source: SEC/Edgar
March 06, 2017
Form 4
Source: SEC/Edgar
March 06, 2017
Form 4
Source: SEC/Edgar
March 06, 2017
Form 4
Source: SEC/Edgar
March 06, 2017
Form 4
Source: SEC/Edgar
March 06, 2017
Form 4
Source: SEC/Edgar
March 06, 2017
Form 4
Source: SEC/Edgar
March 01, 2017
Form 4
Source: SEC/Edgar
March 01, 2017
Form 5
Source: SEC/Edgar
February 13, 2017
Form 4
Source: SEC/Edgar
January 26, 2017
Form 4
Source: SEC/Edgar
January 11, 2017
Form 4
Source: SEC/Edgar
January 09, 2017
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.